Skip to main content
UniHealth

Doctor search

Ariele Lauren Greenfield, MD

Neurology · Mountain View

NPI 1114214566

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
2 carriers
Office
1

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: 757662 · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

14 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Greenfield’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A122857 · Current

Licensed to practise in California · since 2012 · expires 2028-08-31 · University of California, San Diego School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$50,033

Medicare paid this office $50,033 for 144 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)89$20,380$153
Return visit (30+ min)45$5,899$118
New patient visit (60+ min)22$4,408$200
Short return visit (20+ min)30$2,956$84
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or35$2,238$29
See all 6 services
Every Original Medicare service billed
Long return visit (40+ min)89$20,380$153
Return visit (30+ min)45$5,899$118
New patient visit (60+ min)22$4,408$200
Short return visit (20+ min)30$2,956$84
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or35$2,238$29
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's82$2,132$15

Who their Medicare patients are

144 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 15% · Women 60% · Also on Medicaid 10% · Health risk score 1.24. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 62% · Depression 33% · Coronary heart disease 20% · Diabetes 17% · Atrial fibrillation 15% · Cancer 14% · Chronic kidney disease 13% · Dementia 13% · Stroke 13% · Heart failure 10%.

The office billed $179,111, Medicare allowed $66,932 and paid $50,033; for 2,035 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241442,035731.24$179,111$50,033
2023125253731.17$94,562$27,190
2022187543731.30$191,344$61,710
2021189423761.32$174,668$58,131
2020124243761.10$108,091$33,503
20193956711.53$31,026$7,842
20182132591.29$19,659$2,131
20172225581.58$18,784$2,463
20161722541.36$14,105$1,788

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Long return visit (40+ min)84$16,146$148
Return visit (30+ min)29$3,462$108
New patient visit (60+ min)12$2,179$182
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or35$1,751$30
Short return visit (20+ min)14$1,068$76

2022: 6 services

Original Medicare services billed in 2022
Long return visit (40+ min)114$32,006$166
Return visit (30+ min)59$8,637$114
New patient visit (60+ min)39$7,552$194
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or61$4,187$30
Short return visit (20+ min)33$3,113$89
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes12$1,602$94

2021: 6 services

Original Medicare services billed in 2021
Long return visit (40+ min)93$23,421$170
New patient visit (60+ min)102$19,789$194
Return visit (30+ min)43$6,266$125
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or34$1,778$31
Short return visit (20+ min)21$1,621$77
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes13$1,511$94

2020: 4 services

Original Medicare services billed in 2020
New patient visit (60+ min)62$11,075$179
Long return visit (40+ min)41$8,405$136
Return visit (30+ min)34$4,614$103
New patient visit (45+ min)18$2,798$155

2019: 2 services

Original Medicare services billed in 2019
New patient visit (60+ min)12$2,181$182
Long return visit (40+ min)16$1,521$95

2018: 1 service

Original Medicare services billed in 2018
Long return visit (40+ min)15$1,737$83

2017: 1 service

Original Medicare services billed in 2017
Long return visit (40+ min)15$1,361$85

Drugs they prescribed that Part D paid

$521,223

Pharmacies billed $521,223 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

757 generic and fewer than 11 brand-name prescriptions · $521,223 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
VumerityNone21$185,669$8,841
AubagioNone12$114,522$9,544
Nurtec OdtNone11$35,071$3,188
TeriflunomideNone15$24,783$1,652
EmgalityMigraine11$12,875$1,170
See all 24 drugs
Every Part D drug this clinician prescribed
VumerityNone21$185,669$8,841
AubagioNone12$114,522$9,544
Nurtec OdtNone11$35,071$3,188
TeriflunomideNone15$24,783$1,652
EmgalityMigraine11$12,875$1,170
Dalfampridine ErNone34$7,888$232
MemantineNone57$4,018$70
Carbidopa-LevodopaNone111$3,104$28
BaclofenNone26$1,452$56
CarbamazepineNone31$1,307$42
LevetiracetamNone34$1,287$38
GabapentinNone63$1,239$20
DonepezilNone69$890$13
PrometheganNone12$673$56
SumatriptanNone15$583$39
Eletriptan HbrNone11$510$46
PropranololNone18$419$23
PregabalinNone16$275$17
RizatriptanNone22$227$10
TizanidineNone11$207$19
NortriptylineNone11$144$13
Divalproex Sodium ErNone12$138$11
ClopidogrelNone14$101$7
TopiramateNone13$99$8

Year by year

Part D prescribing by year
2024840161NoneNone$521,223
20237771710% (0)16%$679,642
2022836220None7%$207,078
2021613187None7%$145,302
202026999None5%$20,509
201942170% (0)43%$195,731
201874180% (0)42%$348,169
201758130% (0)19%$91,403
201655None0% (0)None$9,526
201518None0% (0)0%$473
201430None0% (0)None$2,239

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 24 drugs

Part D drugs prescribed in 2023
AubagioNone15$191,710$12,781
AvonexNone15$129,327$8,622
VumerityNone11$90,793$8,254
CopaxoneNone12$67,731$5,644
Nurtec OdtNone27$62,736$2,324
EmgalityMigraine16$17,878$1,117
RytaryParkinson's12$14,970$1,248
Dalfampridine ErNone18$6,835$380
MemantineNone89$5,942$67
Carbidopa-LevodopaNone76$4,791$63
DimethylNone12$2,810$234
LevetiracetamNone36$2,208$61
CarbamazepineNone24$1,444$60
GabapentinNone54$1,327$25
BaclofenNone14$1,260$90
DonepezilNone64$1,118$17
Eletriptan HbrNone11$836$76
PropranololNone26$604$23
SumatriptanNone17$584$34
TizanidineNone14$584$42
NortriptylineNone18$482$27
TopiramateNone13$323$25
ClopidogrelNone11$232$21
PromethazineNone12$133$11

2022: 19 drugs

Part D drugs prescribed in 2022
Nurtec Odt16$32,496$2,031
Memantine67$4,614$69
Carbidopa-Levodopa87$4,610$53
Levetiracetam40$4,597$115
Gabapentin60$2,035$34
Sumatriptan33$1,887$57
Baclofen23$1,514$66
Carbidopa-Levodopa Er18$1,490$83
Donepezil85$1,437$17
Carbamazepine24$1,413$59
Pregabalin24$1,033$43
Propranolol23$580$25
Topiramate13$489$38
Clopidogrel20$382$19
Nortriptyline22$376$17
Promethazine21$284$14
Lamotrigine12$129$11
Atorvastatin12$106$9
Lorazepam12$45$4

2021: 14 drugs

Part D drugs prescribed in 2021
Carbidopa-Levodopa66$3,577$54
Carbidopa-Levodopa Er28$1,935$69
Pregabalin29$1,674$58
Levetiracetam32$1,629$51
Memantine20$1,413$71
Gabapentin72$1,310$18
Donepezil66$1,116$17
Ropinirole13$709$55
Propranolol42$578$14
Nortriptyline18$524$29
Sumatriptan18$466$26
Lamotrigine12$134$11
Clopidogrel11$79$7
Sertraline12$59$5

2020: 8 drugs

Part D drugs prescribed in 2020
Pregabalin22$1,857$84
Carbidopa-Levodopa26$1,063$41
Gabapentin33$671$20
Levetiracetam15$581$39
Propranolol13$378$29
Prednisone14$280$20
Donepezil18$273$15
Clopidogrel11$161$15

2019: 1 drug

Part D drugs prescribed in 2019
Gilenya11$120,285$10,935

2018: 2 drugs

Part D drugs prescribed in 2018
Gilenya11$151,350$13,759
Gabapentin12$333$28

Money from drug and device companies

$30 in 2025

Industry payments by year
202522None$30
202444$1,013$1,057
202222$3,155$3,155
202123$4,955$4,955
202011None$57
201936None$487

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Novartis PharmaceuticalsKesimpta$16
1 payment
  • Meals for Kesimpta · 2025-03-12 · $16
GenentechOcrevus$14
1 payment
  • Meals for Ocrevus · 2025-07-11 · $14
See all 2 published payments
Every published payment
GenentechMeals · 2025-07-11Ocrevus$14
Novartis PharmaceuticalsMeals · 2025-03-12Kesimpta$16
See earlier years (2024, 2022, 2021, 2020, 2019)

2024: $1,057

Payments by company in 2024
TG TherapeuticsBriumvi$1,013
1 payment
  • Consulting for Briumvi · 2024-12-23 · $1,013
Novartis PharmaceuticalsKesimpta$15
1 payment
  • Meals for Kesimpta · 2024-08-07 · $15
GenentechOcrevus$14
1 payment
  • Meals for Ocrevus · 2024-09-20 · $14
AbbvieUbrelvy$14
1 payment
  • Meals for Ubrelvy · 2024-06-14 · $14

2022: $3,155

Payments by company in 2022
GenentechNone$2,145
1 payment
  • Consulting · 2022-07-15 · $2,145
F. Hoffmann-La Roche AGNone$1,010
1 payment
  • Consulting · 2022-01-19 · $1,010

2021: $4,955

Payments by company in 2021
GenentechOcrevus$2,520
2 payments
  • Consulting for Ocrevus · 2021-05-19 · $1,260
  • Consulting for Enspryng · 2021-05-07 · $1,260
Genentech USAOcrevus$2,435
1 payment
  • Consulting for Ocrevus · 2021-03-16 · $2,435

2020: $57

Payments by company in 2020
BiogenNone$57
1 payment
  • Education · 2020-10-14 · $57

2019: $487

Payments by company in 2019
Alexion PharmaceuticalsSoliris$285
3 payments
  • Meals · 2019-12-11 · $122
  • Meals · 2019-11-05 · $97
  • Meals for Soliris · 2019-09-07 · $66
BiogenTysabri$169
2 payments
  • Meals for Tysabri · 2019-10-04 · $23
  • Meals · 2019-03-25 · $146
CelgeneOzanimod$33
1 payment
  • Meals for Ozanimod · 2019-12-04 · $33

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Genentech, Inc. · A Phase III Study To Evaluate the Efficacy and Safety of Fenebrutinib in Adults With Progressive Ms · 2022Their institution$58,645
Genentech, Inc. · A Phase III Study To Evaluate the Efficacy and Safety of Fenebrutinib in Adults With Progressive Ms · 2023Their institution$58,270
Genentech, Inc. · A Phase III Study To Evaluate the Efficacy and Safety of Fenebrutinib in Adults With Progressive Ms · 2025Their institution$57,968
Genentech, Inc. · A Phase III Study To Evaluate the Efficacy and Safety of Fenebrutinib in Adults With Progressive Ms · 2024Their institution$23,055

Professional record

NPI
1114214566
Licence
CA A122857California A122857: Current · expires 2028-08-31
Trained
University of California, San Diego School of Medicine, 2011
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X)
Mailing address
325 Distel Cir, Los Altos, CA, 94022
NPI first listed
2011-07-06
NPI last updated
2019-10-23

This is when the NPI record was last certified, not a medical board exam.